DE3781204D1 - Verfahren zur herstellung von lymphokinaktivierten toetenden zellen. - Google Patents

Verfahren zur herstellung von lymphokinaktivierten toetenden zellen.

Info

Publication number
DE3781204D1
DE3781204D1 DE8787107755T DE3781204T DE3781204D1 DE 3781204 D1 DE3781204 D1 DE 3781204D1 DE 8787107755 T DE8787107755 T DE 8787107755T DE 3781204 T DE3781204 T DE 3781204T DE 3781204 D1 DE3781204 D1 DE 3781204D1
Authority
DE
Germany
Prior art keywords
lymphokinactivated
producing
killing cells
killing
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787107755T
Other languages
English (en)
Other versions
DE3781204T2 (de
Inventor
Kam Hung Leung
John J Rinehart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Ohio State University Research Foundation
Original Assignee
Terumo Corp
Ohio State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp, Ohio State University Research Foundation filed Critical Terumo Corp
Application granted granted Critical
Publication of DE3781204D1 publication Critical patent/DE3781204D1/de
Publication of DE3781204T2 publication Critical patent/DE3781204T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8787107755T 1986-05-30 1987-05-27 Verfahren zur herstellung von lymphokinaktivierten toetenden zellen. Expired - Lifetime DE3781204T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86869786A 1986-05-30 1986-05-30
US07/038,361 US4849329A (en) 1986-05-30 1987-04-20 Process for preparing lymphokine activated killer cells

Publications (2)

Publication Number Publication Date
DE3781204D1 true DE3781204D1 (de) 1992-09-24
DE3781204T2 DE3781204T2 (de) 1993-01-14

Family

ID=26715114

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787107755T Expired - Lifetime DE3781204T2 (de) 1986-05-30 1987-05-27 Verfahren zur herstellung von lymphokinaktivierten toetenden zellen.

Country Status (6)

Country Link
US (1) US4849329A (de)
EP (1) EP0247613B1 (de)
JP (1) JP2540544B2 (de)
CA (1) CA1296667C (de)
DE (1) DE3781204T2 (de)
IE (1) IE59610B1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766920A (en) * 1982-08-11 1998-06-16 Cellcor, Inc. Ex vivo activation of immune cells
US5093115A (en) * 1985-06-11 1992-03-03 The United States Of America As Represented By The Department Of Health And Human Services Method of preparing activated killer monocytes for treating colorectal cancer
SE459008B (sv) * 1986-09-04 1989-05-29 Bioinvent Int Ab Saett att framsstaella humana monoklonala antikroppar
US5057423A (en) * 1987-12-18 1991-10-15 University Of Pittsburgh Method for the preparation of pure LAK-active lymphocytes
DK0460065T3 (da) * 1989-02-21 1994-09-26 Terumo Corp Fremgangsmåde til at fremkalde formering af CD4-lymfocytter
AU6044090A (en) * 1989-07-21 1991-02-22 E.I. Du Pont De Nemours And Company Preparation of human adherent lymphokine-activated killer (a-lak) cells
US5198334A (en) * 1989-07-21 1993-03-30 Terumo Corporation Protection of natural killer cell cytolytic activity in peripheral blood mononuclear cells
US5108760A (en) * 1989-07-21 1992-04-28 Terumo Corporation Enhances lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
US6063373A (en) 1989-09-19 2000-05-16 Maxim Pharmaceuticals, Inc. Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor
JPH04170965A (ja) * 1990-11-01 1992-06-18 Nippon Koutai Kenkyusho:Kk リンパ球の活性化方法
US5374549A (en) * 1991-01-31 1994-12-20 Terumo Corporation Process of enriching adherent CD4+ T cells from monocyte depleted peripheral blood mononuclear cells with interleukin 2 and interleukin 4
JPH04299983A (ja) * 1991-01-31 1992-10-23 Terumo Corp 付着リンホカイン活性化キラー細胞の産生・増加方法
WO1993005394A1 (en) * 1991-09-11 1993-03-18 Board Of Regents, The University Of Texas System Identifying membranolytic compounds and precursors thereof
US5429589A (en) * 1992-04-02 1995-07-04 New Dimensions In Medicine, Inc. Hydrogel gauze wound dressing
US5591434A (en) * 1993-05-26 1997-01-07 The United States Of America As Represented By The Secretary Of Agriculture DNA sequence encoding surface protein of cryptosporidium parvum
WO1996005289A1 (en) * 1994-08-08 1996-02-22 Syntello, Inc. Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
US6071942A (en) 1996-05-14 2000-06-06 Maxim Pharmaceuticals, Inc. Elevation of circulating blood histamine levels
US5961969A (en) * 1996-05-14 1999-10-05 Maxim Pharmaceuticals, Inc. Stable circulating histamine levels
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
AU2002366044A1 (en) * 2001-11-22 2003-06-10 Medigenes Interleukin-2 gene transferred lymphokine activated killer cells
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
DE102011106914B4 (de) 2011-07-08 2015-08-27 Zellwerk Gmbh Mäander- Bioreaktor und Verfahren zu dynamischen Expansion, Differenzierung und Ernte von hämatopoetischen Zellen
AU2021207652B2 (en) 2020-01-14 2023-08-03 Synthekine, Inc. Biased IL2 muteins methods and compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752602A (en) * 1985-09-09 1988-06-21 Board Of Regents, The University Of Texas System Dipeptide alkyl esters and their uses

Also Published As

Publication number Publication date
IE871414L (en) 1987-11-30
US4849329A (en) 1989-07-18
EP0247613B1 (de) 1992-08-19
JP2540544B2 (ja) 1996-10-02
IE59610B1 (en) 1994-03-09
CA1296667C (en) 1992-03-03
EP0247613A2 (de) 1987-12-02
DE3781204T2 (de) 1993-01-14
EP0247613A3 (en) 1988-11-17
JPS6328388A (ja) 1988-02-06

Similar Documents

Publication Publication Date Title
DE3781204D1 (de) Verfahren zur herstellung von lymphokinaktivierten toetenden zellen.
DE3762745D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylthiazol.
DE3763558D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylpyridin.
DE3880440D1 (de) Verfahren zur herstellung von apoaequorin.
DE3773889D1 (de) Verfahren zur herstellung von merkaptomethylphenolen.
DE3853160D1 (de) Verfahren zur herstellung von elektrophotographien.
DE3780704D1 (de) Verfahren zur herstellung von n-acyltetrahydroisochinoline.
DE3785530D1 (de) Verfahren zur herstellung von l-arginin.
DE3587333D1 (de) Verfahren zur herstellung von festen loesungen.
DE3775918D1 (de) Verfahren zur herstellung von trockenkaese.
DE3684533D1 (de) Verfahren zur herstellung von ketogulonsaeure.
DE3776485D1 (de) Verfahren zur herstellung von methacrylsaeure.
DE3783565D1 (de) Verfahren zur herstellung von oligosacchariden.
DE3764781D1 (de) Verfahren zur herstellung von trockener alkansulfonsaeure.
DE3783303D1 (de) Verfahren zur herstellung von oligosacchariden.
DE3785723D1 (de) Verfahren zur herstellung von polyolefinen.
DE3776440D1 (de) Verfahren zur herstellung von 5-aminosalicylsaeure.
DE3768426D1 (de) Verfahren zur herstellung von 4,4'-biphenyldicarbonsaeure.
DE3766910D1 (de) Verfahren zur herstellung von dihydrocyclocitral.
DE3769076D1 (de) Verfahren zur herstellung von fluorbenzaldehyden.
DE3774298D1 (de) Verfahren zur herstellung von polyolefinen.
DE3862054D1 (de) Verfahren zur herstellung von trifluormethansulfonsaeure.
DE3765888D1 (de) Verfahren zur herstellung von l-dopa.
DE3769263D1 (de) Verfahren zur herstellung von bromfluoroethylhypofluorit.
DE3777475D1 (de) Verfahren zur herstellung von polyphenylen-ether-polyester-copolymeren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition